V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20194861 | 20124722 | 1.63 | 68.1 | Palliative (P) | 2016-11-11 | 2016-11-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101760848 |
| 20194869 | 20124723 | 1.59 | 87.6 | Palliative (P) | 2018-07-31 | 2018-08-28 | Docetaxel | 02 | N | DOCETAXEL | 101647796 |
| 20194870 | 20124724 | 1.63 | 51.8 | null | 2018-08-20 | 2018-09-04 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100411989 |
| 20194871 | 20124725 | 1.76 | 88.3 | Palliative (P) | 2018-01-24 | 2018-01-24 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100805802 |
| 20194872 | 20124726 | 1.65 | 65.3 | 03 | 2017-12-07 | 2018-01-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101772755 |
| 20194876 | 20124727 | 1.9 | 49.6 | null | 2016-10-04 | 2016-10-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101842617 |
| 20194877 | 20124728 | 1.81 | 72.8 | Palliative (P) | 2022-01-21 | 2022-01-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100567596 |
| 20194885 | 20124729 | 1.6 | 62.6 | Palliative (P) | 2017-01-13 | 2017-01-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101546328 |
| 20194888 | 20124730 | 1.69 | 64 | Palliative (P) | 2018-09-09 | 2018-09-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101621066 |
| 20194892 | 20124731 | 1.36 | 70.4 | Palliative (P) | 2016-11-27 | 2016-12-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100550979 |
| 20194893 | 20124732 | 1.7 | 61.5 | Neo-adjuvant (N) | 2019-07-09 | 2019-07-11 | Docetaxel | 02 | N | DOCETAXEL | 100577461 |
| 20194899 | 20124733 | 1.7 | 55 | null | 2017-10-19 | 2017-10-22 | Docetaxel | 02 | null | DOCETAXEL | 101291660 |
| 20194902 | 20124734 | 1.78 | 92 | null | 2019-01-27 | 2019-02-10 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101771432 |
| 20194903 | 20124735 | null | 88.8 | Palliative (P) | 2020-01-31 | 2020-02-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100165893 |
| 20194909 | 20124736 | 1.67 | 52 | Palliative (P) | 2018-09-24 | 2020-01-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100170534 |
| 20194915 | 20124737 | 1.93 | 89.65 | Adjuvant (A) | 2019-08-30 | 2019-08-31 | Docetaxel | 02 | N | DOCETAXEL | 100514606 |
| 20194916 | 20124738 | 1.76 | 95 | null | 2018-10-04 | 2018-10-04 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100438290 |
| 20194918 | 20124739 | 1.52 | 74.7 | Palliative (P) | 2016-07-25 | 2016-08-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100948621 |
| 20194933 | 20124740 | 1.7 | 71.4 | null | 2017-09-18 | 2017-10-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101369937 |
| 20194937 | 20124741 | 1.51 | 58 | Adjuvant (A) | 2019-07-16 | 2019-07-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101104107 |
| 20194938 | 20124742 | 1.9 | 86 | Palliative (P) | 2016-08-25 | 2017-06-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101360944 |
| 20194939 | 20124743 | 1.74 | 55 | Palliative (P) | null | 2016-07-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100254507 |
| 20194940 | 20124744 | 1.63 | 71.7 | null | 2018-05-20 | 2018-05-20 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100942226 |
| 20194941 | 20124745 | 1.7 | 58 | null | 2019-01-04 | 2019-01-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101319888 |
| 20194949 | 20124746 | 1.67 | 70.7 | Neo-adjuvant (N) | 2017-03-03 | 2017-03-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100170013 |
| 20194951 | 20124747 | 1.59 | 68.3 | Palliative (P) | 2020-09-26 | 2020-10-10 | Docetaxel | 02 | N | DOCETAXEL | 101479584 |
| 20194952 | 20124748 | 2 | 100 | Palliative (P) | 2019-09-09 | 2020-05-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101521244 |
| 20194953 | 20124749 | 1.7 | 71.5 | Palliative (P) | 2016-11-17 | 2017-03-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100308673 |
| 20194955 | 20124750 | 1.67 | 95.2 | Palliative (P) | 2016-07-26 | 2016-08-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101456109 |
| 20194956 | 20124751 | 1.62 | 70 | Palliative (P) | 2016-05-01 | 2016-05-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100531686 |
| 20194958 | 20124752 | 1.76 | 54 | Curative (C) | 2017-06-15 | 2017-07-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101713535 |
| 20194962 | 20124753 | 1.72 | 61.6 | Palliative (P) | 2016-05-19 | 2016-07-08 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100975549 |
| 20194964 | 20124754 | 1.67 | 71.6 | Curative (C) | 2019-12-17 | 2019-12-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101267483 |
| 20194965 | 20124755 | 1.75 | 59.7 | Adjuvant (A) | 2018-09-10 | 2019-09-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101299289 |
| 20194968 | 20124756 | 1.73 | 70 | Palliative (P) | 2018-07-08 | 2019-07-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101100690 |
| 20194972 | 20124757 | 1.69 | 81.9 | Palliative (P) | 2018-10-09 | 2018-10-22 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100575128 |
| 20194975 | 20124758 | 1.69 | 69.7 | Palliative (P) | 2021-09-15 | 2021-09-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100210279 |
| 20194977 | 20124759 | 1.61 | 61.5 | Neo-adjuvant (N) | 2016-06-23 | 2016-06-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101228183 |
| 20194986 | 20124760 | 1.67 | 66.5 | Palliative (P) | 2018-01-24 | 2018-01-27 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100409408 |
| 20194987 | 20124761 | 1.84 | 53.1 | Palliative (P) | 2019-11-14 | 2019-12-13 | Docetaxel | 02 | N | DOCETAXEL | 101413509 |
| 20194989 | 20124762 | 0 | 90.6 | Neo-adjuvant (N) | 2019-12-15 | 2020-03-19 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100734493 |
| 20194993 | 20124763 | 1.74 | 54.4 | Palliative (P) | 2021-05-13 | 2021-09-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101427435 |
| 20194999 | 20124764 | 1.93 | 109 | null | 2016-11-19 | 2016-11-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101606783 |
| 20195011 | 20124765 | 1.67 | 60 | Palliative (P) | 2018-07-02 | 2018-07-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101697566 |
| 20195018 | 20124766 | 1.83 | 40.2 | null | 2019-08-06 | 2019-08-06 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101160910 |
| 20195021 | 20124767 | 1.81 | 66 | Neo-adjuvant (N) | 2017-06-18 | 2017-06-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100280301 |
| 20195024 | 20124768 | 1.72 | 69.8 | Palliative (P) | 2017-11-09 | 2017-11-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100506585 |
| 20195031 | 20124769 | 1.74 | 71 | null | 2018-09-09 | 2018-09-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100593671 |
| 20195034 | 20124770 | 1.6 | 90.4 | null | 2017-11-14 | 2017-11-17 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101801609 |
| 20195038 | 20124771 | 1.7 | 79.8 | Curative (C) | 2020-04-27 | 2020-04-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101207605 |